Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of protein/gene IFI30 related to breast cancer occurrence and development

A breast cancer and gene technology, applied in the application field of protein/gene IFI30, can solve the problems of breast cancer molecular typing marker prognosis and personalized treatment that have not been reported in literature

Inactive Publication Date: 2020-08-25
余之刚
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] At present, there is no literature report on IFI30 as a marker for molecular classification of breast cancer and guiding prognosis and personalized treatment

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of protein/gene IFI30 related to breast cancer occurrence and development
  • Application of protein/gene IFI30 related to breast cancer occurrence and development
  • Application of protein/gene IFI30 related to breast cancer occurrence and development

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0082] In order to enable those skilled in the art to better understand the technical solutions in the present invention, the technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described The embodiments are only some of the embodiments of the present invention, not all of them. Based on the embodiments of the present invention, all other embodiments obtained by persons of ordinary skill in the art without making creative efforts shall fall within the protection scope of the present invention.

[0083] The application of the protein / gene IFI30 related to the occurrence and development of breast cancer of the present invention is specifically, the application of the reagents that change the expression level of IFI30 in evaluating the progress, prognosis and treatment responsiveness of breast cancer. Among them, low expression of...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Apertureaaaaaaaaaa
Absorbanceaaaaaaaaaa
Absorbanceaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the technical field of biological medicines, particularly relates to application of protein / gene IFI30 related to breast cancer occurrence and development, and particularly provides application of the protein / gene IFI30 related to breast cancer occurrence and development, especially application value of the protein / gene IFI30 as a breast cancer molecular typing marker andapplication of the protein / gene IFI30 in preparation of a breast cancer molecular typing kit. The invention also provides a method for screening potential drugs for treating breast cancer. Whether thecandidate is a potential drug for treating breast cancer or not is judged by adjusting the expression level of the biomarker.

Description

technical field [0001] The invention belongs to the technical field of biomedicine, and specifically relates to the application of a protein / gene IFI30 related to the occurrence and development of breast cancer. Background technique [0002] Breast cancer is one of the most common malignant tumors in women, usually occurring in the glandular epithelial tissue of the breast. According to statistics, the incidence rate accounts for 7-10% of various malignant tumors in the whole body, and only about 1-2% of breast cancer patients are men. Second only to uterine cancer in women, its incidence is often related to heredity, and the incidence rate of women before and after menopause is higher between the ages of 40 and 60. It is the most common malignant disease that seriously affects women's physical and mental health and even threatens their lives. one of the tumors. [0003] Although the systemic treatment of breast cancer has made remarkable progress, many patients still suff...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12Q1/6886G01N33/574A61K45/00A61K48/00A61K38/17A61P35/00A61P15/14
CPCA61K38/1709A61K45/00A61K48/0008A61K48/005A61P15/14A61P35/00C12Q1/6886C12Q2600/118C12Q2600/136C12Q2600/158G01N33/57415G01N33/57496G01N2333/47
Inventor 相玉娟叶春淼其他发明人请求不公开姓名
Owner 余之刚
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products